文献速递肿瘤 PET/CT放射性药物与辐射防护

[99mTc]Tc-Galacto-RGD2整合素αvβ3靶向显像作为肺癌分子表型替代标志物的真实世界数据

[99mTc]Tc-Galacto-RGD2 integrin αvβ3-targeted imaging as a surrogate for molecular phenotyping in lung cancer: real-world data.
PubMed 文献 · EJNMMI Res · 2021-06-13

该前瞻性研究纳入185例肺癌和25例良性肺疾病患者,行[99mTc]Tc-Galacto-RGD2 SPECT/CT显像,以T/N比值2.5为截断值,诊断灵敏度91.89%、特异性48.0%、准确率86.67%。非小细胞肺癌整合素αvβ3表达高于小细胞肺癌,晚期高于早期,但肿瘤摄取与αvβ3表达无显著相关。

要点

  • T/N截断值2.5时灵敏度高但特异性有限。
  • 非小细胞肺癌αvβ3表达高于小细胞肺癌。
  • 肿瘤摄取与αvβ3表达无显著相关。

核心结论

  • [99mTc]Tc-Galacto-RGD2 SPECT/CT检测原发性肺癌灵敏度高但特异性有限。
  • 肿瘤血管和肿瘤细胞膜的整合素表达共同贡献肿瘤摄取。

研究设计与样本

  • 所有患者行[99mTc]Tc-Galacto-RGD2显像,以肿瘤/正常组织比值(T/N)表示摄取。
  • 66例恶性疾病和7例良性疾病患者获取肿瘤标本进行αvβ3、CD31、Ki-67和CXCR4分析。

主要发现

  • 肺癌患者包括22例小细胞肺癌、48例鳞状细胞癌、97例腺癌和18例其他类型。
  • 非小细胞肺癌整合素αvβ3表达高于小细胞肺癌,鳞状细胞癌新生血管更密集且αvβ3表达更高。
  • 晚期(III、IV期)整合素αvβ3表达显著高于早期(I、II期)。
  • 肿瘤摄取与αvβ3表达之间无显著相关性。

关键数值与推荐

  • 以T/N比值2.5为截断值,[99mTc]Tc-Galacto-RGD2 SPECT/CT诊断灵敏度91.89%、特异性48.0%、准确率86.67%。

临床怎么用

  • 可用于肺癌原发灶检测,但需注意特异性有限。
  • 整合素αvβ3显像可能反映肿瘤血管和细胞膜整合素表达,但肿瘤摄取与αvβ3表达无显著相关,解读需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitors (TKIs) are beneficial in patients with lung cancer. We explored the clinical value of [99mTc]Tc-Galacto-RGD2 single-photon emission computed tomography (SPECT/CT) in patients with lung cancer, integrin αvβ3 expression, and neovascularization in lung cancer subtypes was also addressed. METHODS: A total of 185 patients with lung cancer and 25 patients with benign lung diseases were enrolled in this prospective study from January 2013 to December 2016. All patients underwent [99mTc]Tc-Galacto-RGD2 imaging. The region of interest was drawn around each primary lesion, and tumour uptake of [99mTc]Tc-Galacto-RGD2 was expressed as the tumour/normal tissue ratio(T/N). The diagnostic efficacy was evaluated by receiver operating characteristic curve analysis. Tumour specimens were obtained from 66 patients with malignant diseases and 7 with benign disease. Tumour expression levels of αvβ3, CD31, Ki-67, and CXCR4 were further analysed for the evaluation of biological behaviours. RESULTS: The lung cancer patients included 22 cases of small cell lung cancer (SCLC), 48 squamous cell carcinoma (LSC), 97 adenocarcinoma (LAC), and 18 other types of lung cancer. The sensitivity, specificity, and accuracy of [99mTc]Tc-Galacto-RGD2 SPECT/CT using a cut-off value of T/N ratio at 2.5 were 91.89%, 48.0%, and 86.67%, respectively. Integrin αvβ3 expression was higher in non-SCLC compared with SCLC, while LSC showed denser neovascularization and higher integrin αvβ3 expression. Integrin αvβ3 expression levels were significantly higher in advanced (III, IV) than early stages (I, II). However, there was no significant correlation between tumour uptake and αvβ3 expression. CONCLUSIONS: [99mTc]Tc-Galacto-RGD2 SPECT/CT has high sensitivity but limited specificity for detecting primary lung cancer, integrin expression in the tumour vessel and tumour cell membrane contributes to the tumour uptake.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Fu J, Xie Y, Fu T, et al. [99mTc]Tc-Galacto-RGD2 integrin αvβ3-targeted imaging as a surrogate for molecular phenotyping in lung cancer: real-world data. EJNMMI Res. 2021. PMID: 34121134. doi:10.1186/s13550-021-00801-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。